FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul de Jong

Research Profile

Disorders

Physiology

Glomerular Filtration Rate

Anatomy

Kidneys

Chemicals & Drugs

Concepts & Ideas

Phenomena

Renal Circulation

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Paul A Smink; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Hiddo J Lambers Heerspink; Dick De Zeeuw
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
Solmaz Assa; Paul E de Jong; Yoran M Hummel; Johanna Kuipers; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
Lieneke Scheven; L Joost van Pelt; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Jenny E Kootstra; Hiddo J Lambers Heerspink
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul de Jong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Paul A Smink; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Hiddo J Lambers Heerspink; Dick De Zeeuw
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(5):804-11.
2012: Solmaz Assa; Paul E de Jong; Yoran M Hummel; Johanna Kuipers; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(10):1615-23.
2012: Lieneke Scheven; L Joost van Pelt; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Jenny E Kootstra; Hiddo J Lambers Heerspink
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
European heart journal 2012;33(18):2272-81.
2012: Solmaz Assa; Judith J Dasselaar; Paul E de Jong; Riemer H J A Slart; René A Tio; Adriaan A Voors; Casper F M Franssen
Comparison of cardiac positron emission tomography perfusion defects during stress induced by hemodialysis versus adenosine.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(6):862-4.
2012: Marije van der Velde; Stephan J L Bakker; Aminu K Bello; Auke H Brantsma; Paul E de Jong; Meguid El Nahas; Ronald T Gansevoort
Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(6):2275-83.
2012: Ferdau L Nauta; Wim van Oeveren; Hiddo Lambers Heerspink; Stephan J L Bakker; Henk Bilo; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Effect of frozen storage on urinary concentration of kidney damage markers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(4):586-9.
2011: Nynke Halbesma; Martijn W Heymans; Desiree F Jansen; Ronald P Stolk; Paul E de Jong; Ron T Gansevoort
Development and validation of a general population renal risk score.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(7):1731-8.
2011: Ron T Gansevoort; Andrew S Levey; Kunihiro Matsushita; Marije van der Velde; Mark Woodward; Brad C Astor; Josef Coresh; Paul E de Jong
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Kidney international 2011;80(1):93-104.
2011: Andrew S Levey; Kunihiro Matsushita; Meguid El Nahas; Ron T Gansevoort; Bertram L Kasiske; Brad C Astor; Josef Coresh; Paul E de Jong; Kai-Uwe Eckardt
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
Kidney international 2011;80(1):17-28.
2011: Hanneke Joosten; Joris P J Slaets; Sipke T Visser; Henk J G Bilo; Paul E de Jong; Gerbrand J Izaks; Ron T Gansevoort
Association of cognitive function with albuminuria and eGFR in the general population.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(6):1400-9.
2011: Ferdau L Nauta; Stephan J L Bakker; Wim van Oeveren; gerjan navis; Jaap J Homan van der Heide; Harry van Goor; Paul E de Jong; Ron T Gansevoort
Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(5):733-43.
2011: Esther Meijer; Stephan J L Bakker; Eric J van der Jagt; gerjan navis; Paul E de Jong; Joachim Struck; Ron T Gansevoort
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(2):361-8.
2010: Esther Meijer; Wendy E Boertien; Ferdau L Nauta; Stephan J L Bakker; Wim van Oeveren; Mieneke Rook; Eric J van der Jagt; Harry van Goor; Dorien J M Peters; gerjan navis; Paul E de Jong; Ron T Gansevoort
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;56(5):883-95.
2010: Marije van der Velde; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Influence of age and measure of eGFR on the association between renal function and cardiovascular events.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(11):2053-9.
2010: Akin Özyilmaz; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(11):3560-8.
2010: Ali Abbasi; Eva Corpeleijn; Douwe Postmus; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Joachim Struck; Hans L Hillege; Ronald P Stolk; gerjan navis; Stephan J L Bakker
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2010;95(9):E26-31.
2010: Cornelis Boersma; Ron T Gansevoort; Petros Pechlivanoglou; Sipke T Visser; Flip F J van Toly; Lolkje T W de Jong van den Berg; Paul E de Jong; Maarten J Postma
Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Clinical therapeutics 2010;32(6):1103-21.
2010: Esther Meijer; Mieneke Rook; Hilde Tent; gerjan navis; Eric J van der Jagt; Paul E de Jong; Ron T Gansevoort
Early renal abnormalities in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(6):1091-8.
2010: Nynke Halbesma; Desiree F Jansen; Ronald P Stolk; Paul E de Jong; Ron T Gansevoort
Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(6):1846-53.
2010: Ron T Gansevoort; Paul E de Jong
Challenges for the present CKD classification system.
Current opinion in nephrology and hypertension 2010;19(3):308-14.
2010: Gerard C M Linssen; Stephan J L Bakker; Adriaan Voors; Ron T Gansevoort; Hans L Hillege; Paul E de Jong; Dirk J van Veldhuisen; Rijk O B Gans; Dick De Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
European heart journal 2010;31(1):120-7.
2010: Esther Meijer; Stephan J L Bakker; Nynke Halbesma; Paul E de Jong; Joachim Struck; Ron T Gansevoort
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort.
Kidney international 2010;77(1):29-36.
2009: Leendert H Oterdoom; Ron T Gansevoort; Jan Schouten; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.
Atherosclerosis 2009;207(2):534-40.
2009: Nynke Halbesma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
High protein intake associates with cardiovascular events but not with loss of renal function.
Journal of the American Society of Nephrology : JASN 2009;20(8):1797-804.
2009: Leendert H Oterdoom; Aiko P J de Vries; Rutger M van Ree; Ron T Gansevoort; Willem J Van Son; Jaap J Homan van der Heide; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population.
Transplantation 2009;87(10):1562-70.
2009: Esther Meijer; Paul E de Jong; Eric J van der Jagt; D orienJ Peters; Martijn H Breuning; Ron T Gansevoort
[Autosomal dominant polycystic kidney disease: new insights and possible drugs].
Nederlands tijdschrift voor geneeskunde 2009;153(20):968-74.
2009: Marije van der Velde; Nynke Halbesma; Frank T de Charro; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Screening for albuminuria identifies individuals at increased renal risk.
Journal of the American Society of Nephrology : JASN 2009;20(4):852-62.
2009: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Fasting insulin is a stronger cardiovascular risk factor in women than in men.
Atherosclerosis 2009;203(2):640-6.
2009: Ron T Gansevoort; Paul E de Jong
The case for using albuminuria in staging chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2009;20(3):465-8.
2009: Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick De Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort
First morning voids are more reliable than spot urine samples to assess microalbuminuria.
Journal of the American Society of Nephrology : JASN 2009;20(2):436-43.
2009: Judith J Dasselaar; Riemer H J A Slart; Martine Knip; Jan Pruim; René A Tio; CHRISTOPHER MCINTYRE; Paul E de Jong; Casper F M Franssen
Haemodialysis is associated with a pronounced fall in myocardial perfusion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(2):604-10.
2009: Paul E de Jong; Ron T Gansevoort
Focus on microalbuminuria to improve cardiac and renal protection.
Nephron. Clinical practice 2009;111(3):c204-10; discussion c211.
2008: Paul E de Jong; gerjan navis
Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease.
Nature clinical practice. Nephrology 2008;4(12):654-5.
2008: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(12):3851-8.
2008: Hiddo J Lambers Heerspink; Auke H Brantsma; Dick De Zeeuw; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
American journal of epidemiology 2008;168(8):897-905.
2008: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Extended prognostic value of urinary albumin excretion for cardiovascular events.
Journal of the American Society of Nephrology : JASN 2008;19(9):1785-91.
2008: Leendert H Oterdoom; Rutger M van Ree; Aiko P J de Vries; Ron T Gansevoort; Jan Schouten; Willem J Van Son; Jaap J Homan van der Heide; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Transplantation 2008;86(3):391-8.
2008: Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Gender differences in predictors of the decline of renal function in the general population.
Kidney international 2008;74(4):505-12.
2008: Hiddo J Lambers Heerspink; Elsbeth C Witte; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care system.
Kidney international 2008;74(3):377-83.
2008: Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong van den Berg; Ron T Gansevoort
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
British journal of clinical pharmacology 2008;65(5):723-32.
2008: Esther Meijer; Paul E de Jong; Dorien J Peters; Ron T Gansevoort
Better understanding of ADPKD results in potential new treatment options: ready for the cure?
Journal of nephrology 2008;21(2):133-8.
2008: Paul E de Jong; Marije van der Velde; Ron T Gansevoort; Carmine Zoccali
Screening for chronic kidney disease: where does Europe go?
Clinical journal of the American Society of Nephrology : CJASN 2008;3(2):616-23.
2008: A Titia Lely; Frank G H van Der Kleij; Taco J Kistemaker; Alfred J Apperloo; Paul E de Jong; Dick De Zeeuw; gerjan navis
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(1):54-60.
2008: Christiane A Geluk; Wendy J Post; Hans L Hillege; René A Tio; Jan G P Tijssen; RB van Dijk; W Arnold Dijk; Stephan J L Bakker; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.
Atherosclerosis 2008;196(1):372-82.
2008: Folkert Asselbergs; Pim van der Harst; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
Atherosclerosis 2008;196(1):349-55.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of screening for cardio-renal risk factors on drug use in the general population.
British journal of clinical pharmacology 2007;64(6):810-8.
2007: Judith J Dasselaar; Roel M Huisman; Paul E de Jong; Casper F M Franssen
Relative blood volume measurements during hemodialysis: comparisons between three noninvasive devices.
Hemodialysis international. International Symposium on Home Hemodialysis 2007;11(4):448-55.
2007: Tom D J Smilde; Mike W Zuurman; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst; Gerrit van der Steege; Adriaan A Voors; Jan A Kors; Paul E de Jong; gerjan navis
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: Sijrike F van der Mei; Willem J Van Son; Eric van Sonderen; Paul E de Jong; Johan W Groothoff; Wim J A van den Heuvel
Factors determining social participation in the first year after kidney transplantation: a prospective study.
Transplantation 2007;84(6):729-37.
2007: Sascha Gross; Rutger M van Ree; Leendert H Oterdoom; Aiko P J de Vries; Willem J Van Son; Paul E de Jong; gerjan navis; Mike W Zuurman; Angelika Bierhaus; Rijk O B Gans; Stephan J L Bakker
Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients.
Transplantation 2007;84(5):659-63.
2007: Jacoline W Brinkman; Dick De Zeeuw; Hiddo J Lambers Heerspink; Ron T Gansevoort; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry.
Clinical chemistry 2007;53(8):1520-6.
2007: Paul E de Jong; Ron T Gansevoort; Stephan J L Bakker
Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
Journal of nephrology 2007;20(4):375-80.
2007: Judith J Dasselaar; Marjolijn N Lub-de Hooge; Jan Pruim; Hugo Nijnuis; Anneke Wiersum; Paul E de Jong; Roel M Huisman; Casper F M Franssen
Relative blood volume changes underestimate total blood volume changes during hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):669-74.
2007: Judith J Dasselaar; Paul E de Jong; Roel M Huisman; Casper F M Franssen
Influence of ultrafiltration volume on blood volume changes during hemodialysis as observed in day-of-the-week analysis of hemodialysis sessions.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2007;53(4):479-84.
2007: Wouter B A Eijkelkamp; Pieter A de Graeff; Dirk J van Veldhuisen; Richard P E van Dokkum; Ron T Gansevoort; Paul E de Jong; Dick De Zeeuw; Hans L Hillege
Effect of first myocardial ischemic event on renal function.
The American journal of cardiology 2007;100(1):7-12.
2007: Aminu K Bello; Dick De Zeeuw; Meguid El Nahas; Auke H Brantsma; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Impact of weight change on albuminuria in the general population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1619-27.
2007: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Fasting insulin modifies the relation between age and renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1587-92.
2007: Judith J Dasselaar; Roel M Huisman; Paul E de Jong; Johannes G M Burgerhof; Casper F M Franssen
Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2007;53(3):357-64.
2007: Susanna E Borggreve; Hans L Hillege; Geesje M Dallinga-Thie; Paul E de Jong; Bruce Wolffenbuttel; Diederick Grobbee; Arie Van Tol; R P F Dullaart
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
European heart journal 2007;28(8):1012-8.
2007: Sijrike F van der Mei; Eric van Sonderen; Willem J Van Son; Paul E de Jong; Johan W Groothoff; Wim J A van den Heuvel
Social participation after successful kidney transplantation.
Disability and rehabilitation 2007;29(6):473-83.
2007: Renate J Bosma; A J Kwakernaak; Jaap J Homan van der Heide; Paul E de Jong; gerjan navis
Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(3):645-52.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.
British journal of clinical pharmacology 2007;63(2):224-31.
2007: Auke H Brantsma; Jarir Atthobari; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
What predicts progression and regression of urinary albumin excretion in the nondiabetic population?
Journal of the American Society of Nephrology : JASN 2007;18(2):637-45.
2007: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Determinants of insulin resistance in renal transplant recipients.
Transplantation 2007;83(1):29-35.
2007: Christiane A Geluk; Riksta Dikkers; Jan A Kors; René A Tio; Riemer H J A Slart; Rozemarijn Vliegenthart; Hans L Hillege; Tineke P Willems; Paul E de Jong; Wiek H van Gilst; Matthijs Oudkerk; Felix Zijlstra
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study.
BMC cardiovascular disorders 2007;7():19.
2007: Christiane A Geluk; René A Tio; Jan G P Tijssen; RB van Dijk; W A Dijk; Hans L Hillege; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(4):133-41.
2007: Jacoline W Brinkman; Dick De Zeeuw; Ron T Gansevoort; Jacko J Duker; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction.
Clinical chemistry 2007;53(1):153-4.
2007: Rutger M van Ree; Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Jaap J Homan van der Heide; Willem J Van Son; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):246-53.
2006: Jarir Atthobari; Auke H Brantsma; Ron T Gansevoort; Sipke T Visser; Folkert Asselbergs; Wiek H van Gilst; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3106-14.
2006: Ron T Gansevoort; Jacoline W Brinkman; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw
Evaluation of measures of urinary albumin excretion.
American journal of epidemiology 2006;164(8):725-7.
2006: Nynke Halbesma; Dirk-Sjoerd Kuiken; Auke H Brantsma; Stephan J L Bakker; Jack F M Wetzels; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
Journal of the American Society of Nephrology : JASN 2006;17(9):2582-90.
2006: Paul E de Jong; Nynke Halbesma; Ron T Gansevoort
Screening for early chronic kidney disease--what method fits best?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(9):2358-61.
2006: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Mike W Zuurman; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
The Journal of clinical endocrinology and metabolism 2006;91(9):3382-8.
2006: Sijrike F van der Mei; Boudien Krol; Willem J Van Son; Paul E de Jong; Johan W Groothoff; Wim J A van den Heuvel
Social participation and employment status after kidney transplantation: a systematic review.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(6):979-94.
2006: Paul E de Jong; Gary C Curhan
Screening, monitoring, and treatment of albuminuria: Public health perspectives.
Journal of the American Society of Nephrology : JASN 2006;17(8):2120-6.
2006: Jasper W L Hartog; Aiko P J de Vries; Stephan J L Bakker; Reindert Graaff; Willem J Van Son; Jaap J Homan van der Heide; Rijk O B Gans; Bruce Wolffenbuttel; Paul E de Jong; Andries J Smit
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(8):2263-9.
2006: Sijrike F van der Mei; Johan W Groothoff; Eric van Sonderen; Wim J A van den Heuvel; Paul E de Jong; Willem J Van Son
Clinical factors influencing participation in society after successful kidney transplantation.
Transplantation 2006;82(1):80-5.
2006: Paul E de Jong
Equations used to predict glomerular filtration rate perform poorly in kidney transplant recipients.
Nature clinical practice. Nephrology 2006;2(6):300-1.
2006: Paul E de Jong; Ron T Gansevoort
Prevention of chronic kidney disease: the next step forward!
Nephrology (Carlton, Vic.) 2006;11(3):240-4.
2006: Jarir Atthobari; Folkert Asselbergs; Cornelis Boersma; Robin de Vries; Hans L Hillege; Wiek H van Gilst; Ron T Gansevoort; Paul E de Jong; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Clinical therapeutics 2006;28(3):432-44.
2006: Judith J Dasselaar; Paul E de Jong; Roel M Huisman; Casper F M Franssen
Effect of high and low ultrafiltration volume during hemodialysis on relative blood volume.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2006;52(2):169-73.
2006: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion as a predictor of the development of hypertension in the general population.
Journal of the American Society of Nephrology : JASN 2006;17(2):331-5.
2006: Aiko P J de Vries; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker; Ron T Gansevoort
The predictive value of renal vascular resistance for late renal allograft loss.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(2):364-70.
2006: Renate J Bosma; Jan Krikken; Jaap J Homan van der Heide; Paul E de Jong; gerjan navis
Obesity and renal hemodynamics.
Contributions to nephrology 2006;151():184-202.
2006: Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong van den Berg; Paul E de Jong; Dick De Zeeuw; Lieven J P Annemans; Maarten J Postma
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
PharmacoEconomics 2006;24(6):523-35.
2005: Jacoline W Brinkman; Dick De Zeeuw; Jacko J Duker; Ron T Gansevoort; Ido P Kema; Hans L Hillege; Paul E de Jong; Stephan J L Bakker
Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples.
Clinical chemistry 2005;51(11):2181-3.
2005: Paul E de Jong; Ron T Gansevoort
Screening techniques for detecting chronic kidney disease.
Current opinion in nephrology and hypertension 2005;14(6):567-72.
2005: Rutger M van Ree; Aiko P J de Vries; Leendert H Oterdoom; T Hauw The; Ron T Gansevoort; Jaap J Homan van der Heide; Willem J Van Son; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2524-31.
2005: Casper F M Franssen; Judith J Dasselaar; Paulina Sytsma; Johannes G M Burgerhof; Paul E de Jong; Roel M Huisman
Automatic feedback control of relative blood volume changes during hemodialysis improves blood pressure stability during and after dialysis.
Hemodialysis international. International Symposium on Home Hemodialysis 2005;9(4):383-92.
2005: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Diabetes care 2005;28(10):2525-30.
2005: Leendert H Oterdoom; Aiko P J de Vries; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Validation of insulin resistance indexes in a stable renal transplant population.
Diabetes care 2005;28(10):2424-9.
2005: Judith J Dasselaar; Roel M Huisman; Paul E de Jong; Casper F M Franssen
Measurement of relative blood volume changes during haemodialysis: merits and limitations.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2043-9.
2005: Dick De Zeeuw; Hans L Hillege; Paul E de Jong
The kidney, a cardiovascular risk marker, and a new target for therapy.
Kidney international. Supplement 2005;(98):S25-9.
2005: Jorden M Veeneman; Hermi A Kingma; Frans Stellaard; Paul E de Jong; Dirk-Jan Reijngoud; Roel M Huisman
Oxidative metabolism appears to be reduced in long-term hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(1):102-10.
2005: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Stephan J L Bakker; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
The Journal of clinical endocrinology and metabolism 2005;90(7):4198-204.
2005: Christiane A Geluk; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Paul E de Jong; Felix Zijlstra; Wiek H van Gilst
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
European heart journal 2005;26(13):1314-20.
2005: Jasper W L Hartog; Aiko P J de Vries; Helen L Lutgers; Robbert Meerwaldt; Roel M Huisman; Willem J Van Son; Paul E de Jong; Andries J Smit
Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
Annals of the New York Academy of Sciences 2005;1043():299-307.
2005: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
The association between atherosclerotic risk factors and renal function in the general population.
Kidney international 2005;67(5):1967-73.
2005: Ron T Gansevoort; Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.
Kidney international. Supplement 2005;(94):S28-35.
2005: Paul E de Jong; Dick De Zeeuw
Renoprotective therapy: is it blood pressure or albuminuria that matters?
Lancet 2005;365(9463):913-4.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(3):497-508.
2005: Menno J A Kocks; A Titia Lely; Frans Boomsma; Paul E de Jong; gerjan navis
Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man.
Journal of hypertension 2005;23(3):597-602.
2005: Folkert Asselbergs; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
Stroke; a journal of cerebral circulation 2005;36(3):649-53.
2005: Jorden M Veeneman; Hermi A Kingma; Frans Stellaard; Paul E de Jong; Dirk-Jan Reijngoud; Roel M Huisman
Membrane biocompatibility does not affect whole body protein metabolism during dialysis.
Blood purification 2005;23(3):211-8.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: P A Marcel de Vries; Dick De Zeeuw; Paul E de Jong; gerjan navis
The abnormal renal vasodilator response to D1-like receptor stimulation in conscious SHR can be normalized by AT1 blockade.
Journal of cardiovascular pharmacology 2004;44(5):571-6.
2004: Ron T Gansevoort; Bart van der Heij; Coen A Stegeman; Frank T de Charro; Martin G Nieuwenhuizen; Dick De Zeeuw; Paul E de Jong
Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future?
Kidney international. Supplement 2004;(92):S7-10.
2004: Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Hans L Hillege; Ido P Kema; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.
Kidney international. Supplement 2004;(92):S69-75.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.
Kidney international. Supplement 2004;(92):S18-21.
2004: Aiko P J de Vries; Stephan J L Bakker; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Hauw T The; Paul E de Jong; Rijk O B Gans
Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(10):1675-83.
2004: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Wilbert M T Janssen; Ron T Gansevoort; gerjan navis; Dick De Zeeuw; Paul E de Jong
Sodium intake affects urinary albumin excretion especially in overweight subjects.
Journal of internal medicine 2004;256(4):324-30.
2004: Jasper W L Hartog; Andries J Smit; Willem J Van Son; gerjan navis; Rijk O B Gans; Bruce Wolffenbuttel; Paul E de Jong
Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(6):966-75.
2004: Jorden M Veeneman; Hermi A Kingma; Frans Stellaard; Paul E de Jong; Dirk-Jan Reijngoud; Roel M Huisman
Comparison of amino acid oxidation and urea metabolism in haemodialysis patients during fasting and meal intake.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(6):1533-41.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.
Journal of the American Society of Nephrology : JASN 2004;15(5):1316-22.
2004: Wybe D Kloppenburg; Coen A Stegeman; Ton K Kremer Hovinga; Gerard Vastenburg; Pieter Vos; Paul E de Jong; Roel M Huisman
Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(5):1212-23.
2004: Francisca H Jorna; Tom J M Tobé; Roel M Huisman; Paul E de Jong; John T M Plukker; Coen A Stegeman
Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(5):1168-73.
2004: Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.
Kidney international 2004;65(4):1416-21.
2004: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Johannes G M Burgerhof; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein modifies the relationship between blood pressure and microalbuminuria.
Hypertension 2004;43(4):791-6.
2004: Jarir Atthobari; Taco B M Monster; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.
British journal of clinical pharmacology 2004;57(3):328-36.
2004: Folkert Asselbergs; Rudolf A de Boer; Gilles F H Diercks; Bas Langeveld; René A Tio; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?
International journal of cardiology 2004;93(2-3):211-5.
2004: Jorden M Veeneman; Hermi A Kingma; Theo S Boer; Frans Stellaard; Paul E de Jong; Dirk-Jan Reijngoud; Roel M Huisman
The metabolic response to ingested protein is normal in long-term hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):330-41.
2004: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Folkert Asselbergs; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.
Atherosclerosis 2004;172(1):107-14.
2004: Renate J Bosma; Jaap J Homan van der Heide; Eric J Oosterop; Paul E de Jong; gerjan navis
Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects.
Kidney international 2004;65(1):259-65.
2003: PT Luik; Klaas Hoogenberg; Michiel N Kerstens; BJ Beusekamp; Paul E de Jong; R P F Dullaart; gerjan navis
The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
Diabetologia 2003;46(8):1131-9.
2003: Marijke Haas Jimoh Akanbi; Eric De Boer; Paul E de Jong; Frits Moolenaar; Dirk K F Meijer; Dick De Zeeuw
Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Clinical science (London, England : 1979) 2003;105(1):51-7.
2003: Hendrik Bos; Gozewijn D Laverman; Robert H Henning; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw; gerjan navis
Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(2):106-12.
2003: Folkert Asselbergs; Ad J van Boven; Erik M Stuveling; Gilles F H Diercks; Hans L Hillege; Jan A Kors; Paul E de Jong; Wiek H van Gilst
Relation of electrocardiographic abnormalities to levels of serum C-reactive protein.
The American journal of cardiology 2003;91(11):1358-60.
2003: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; gerjan navis; Dick De Zeeuw; Paul E de Jong
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women.
Journal of the American Society of Nephrology : JASN 2003;14(5):1330-5.
2003: Jacobien C Verhave; Corine P Baljé-Volkers; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
The reliability of different formulae to predict creatinine clearance.
Journal of internal medicine 2003;253(5):563-73.
2003: Jorden M Veeneman; Hermi A Kingma; Theo S Boer; Frans Stellaard; Paul E de Jong; Dirk-Jan Reijngoud; Roel M Huisman
Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients.
American journal of physiology. Endocrinology and metabolism 2003;284(5):E954-65.
2003: Aiko P J de Vries; Stephan J L Bakker; Willem J Van Son; Jaap J Homan van der Heide; T Hauw The; Paul E de Jong; Rijk O B Gans
Insulin resistance as putative cause of chronic renal transplant dysfunction.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(4):859-67.
2003: Sara-Joan Pinto-Sietsma; gerjan navis; Wilbert M T Janssen; Dick De Zeeuw; Reinhold O B Gans; Paul E de Jong
A central body fat distribution is related to renal function impairment, even in lean subjects.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(4):733-41.
2003: Pieter L Rensma; Alfred J Apperloo; Paul E de Jong
Why does elevated plasma homocysteine result in severe microvascular injury, but not glomerular damage?
Circulation 2003;107(11):e77; author reply e77.
2003: Taco B M Monster; Paul E de Jong; Lolkje T W de Jong van den Berg
Drug-induced renal function impairment: a population-based survey.
Pharmacoepidemiology and drug safety 2003;12(2):135-43.
2003: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
Kidney international 2003;63(2):654-61.
2003: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van de Berg
Corticosteroid use and its association with microalbuminuria in the adult population.
Pulmonary pharmacology & therapeutics 2003;16(6):349-53.
2003: Paul E de Jong; Hans L Hillege; Sara-Joan Pinto-Sietsma; Dick De Zeeuw
Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(1):10-3.
2003: Gozewijn D Laverman; Harry van Goor; Robert H Henning; Paul E de Jong; Dick De Zeeuw; gerjan navis
Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.
Kidney international 2003;63(1):64-71.
2002: Paul E de Jong; Jacobien C Verhave; Sara-Joan Pinto-Sietsma; Hans L Hillege
Obesity and target organ damage: the kidney.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26 Suppl 4():S21-4.
2002: Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Jan A Kors; Harry J G M Crijns; Diederick Grobbee; Paul E de Jong; Wiek H van Gilst
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes.
Journal of the American College of Cardiology 2002;40(8):1401.
2002: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick De Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick Grobbee; Paul E de Jong
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Circulation 2002;106(14):1777-82.
2002: Wybe D Kloppenburg; Paul E de Jong; Roel M Huisman
The contradiction of stable body mass despite low reported dietary energy intake in chronic haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(9):1628-33.
2002: Gozewijn D Laverman; gerjan navis; Robert H Henning; Paul E de Jong; Dick De Zeeuw
Dual renin-angiotensin system blockade at optimal doses for proteinuria.
Kidney international 2002;62(3):1020-5.
2002: Jacobien C Verhave; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
How to measure the prevalence of microalbuminuria in relation to age and gender?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):436-7; author reply 437.
2002: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.
Pharmacoepidemiology and drug safety 2002;11(5):379-84.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Atherosclerosis 2002;163(1):121-6.
2002: Gilles F H Diercks; Ad J van Boven; J L Hillege; Paul E de Jong; J L Rouleau; Wiek H van Gilst
The importance of microalbuminuria as a cardiovascular risk indicator: A review.
The Canadian journal of cardiology 2002;18(5):525-35.
2002: Hendrik Bos; Robert H Henning; Paul E de Jong; Dick De Zeeuw; gerjan navis
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(5):793-7.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
Diabetes care 2002;25(5):936-7.
2002: PT Luik; Klaas Hoogenberg; Frank G H van Der Kleij; BJ Beusekamp; Michiel N Kerstens; Paul E de Jong; R P F Dullaart; gerjan navis
Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.
Diabetologia 2002;45(4):535-41.
2002: Frank G H van Der Kleij; Paul E de Jong; Robert H Henning; Dick De Zeeuw; gerjan navis
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
Journal of the American Society of Nephrology : JASN 2002;13(4):1025-33.
2002: Marijke Haas Jimoh Akanbi; Frits Moolenaar; Angela Elsinga; Els A Van der Wouden; Paul E de Jong; Dirk K F Meijer; Dick De Zeeuw
Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.
Journal of drug targeting 2002;10(1):81-9.
2002: Hendrik Bos; Robert H Henning; Eric De Boer; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw; gerjan navis
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Kidney international 2002;61(2):473-80.
2002: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.
British journal of clinical pharmacology 2002;53(1):31-6.
2001: Gozewijn D Laverman; Robert H Henning; Paul E de Jong; gerjan navis; Dick De Zeeuw
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(6):1381-4.
2001: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.
Archives of internal medicine 2001;161(16):2000-5.
2001: Hans L Hillege; Wilbert M T Janssen; AA Bak; Gilles F H Diercks; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst; Dick De Zeeuw; Paul E de Jong
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
Journal of internal medicine 2001;249(6):519-26.
2001: H Buter; gerjan navis; R P F Dullaart; Dick De Zeeuw; Paul E de Jong
Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(4):771-5.
2001: Wybe D Kloppenburg; Coen A Stegeman; Paul E de Jong; Roel M Huisman
Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients.
Kidney international 2001;59(3):1165-74.
2001: Jorden M Veeneman; Paul E de Jong; Roel M Huisman; Dirk-Jan Reijngoud
Re: Adey et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 278: E219-E225, 2000.
American journal of physiology. Endocrinology and metabolism 2001;280(1):E197-8.
2000: Gilles F H Diercks; Ad J van Boven; Hans L Hillege; Wilbert M T Janssen; Jan A Kors; Paul E de Jong; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.
European heart journal 2000;21(23):1922-7.
2000: Wilbert M T Janssen; Hans L Hillege; Sara-Joan Pinto-Sietsma; AA Bak; Dick De Zeeuw; Paul E de Jong
Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(11):1107-10.
2000: Sara-Joan Pinto-Sietsma; J Mulder; Wilbert M T Janssen; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.
Annals of internal medicine 2000;133(8):585-91.
2000: Sara-Joan Pinto-Sietsma; Wilbert M T Janssen; Hans L Hillege; gerjan navis; Dick De Zeeuw; Paul E de Jong
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.
Journal of the American Society of Nephrology : JASN 2000;11(10):1882-8.
2000: P van Paassen; Dick De Zeeuw; Paul E de Jong; gerjan navis
Renin inhibition improves pressure natriuresis in essential hypertension.
Journal of the American Society of Nephrology : JASN 2000;11(10):1813-8.
2000: Gilles F H Diercks; Wilbert M T Janssen; Ad J van Boven; AA Bak; Paul E de Jong; Harry J G M Crijns; Wiek H van Gilst
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
The American journal of cardiology 2000;86(6):635-8.
2000: Casper F M Franssen; Coen A Stegeman; Cees G M Kallenberg; Rijk O B Gans; Paul E de Jong; S J Hoorntje; J W Cohen Tervaert
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
Kidney international 2000;57(6):2195-206.
2000: P van Paassen; Dick De Zeeuw; gerjan navis; Paul E de Jong
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(5):637-43.
2000: J Broekroelofs; gerjan navis; Coen A Stegeman; Wim van Der Bij; Wim J de Boer; Dick De Zeeuw; Paul E de Jong
Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss.
Transplantation 2000;69(8):1624-8.
2000: J Broekroelofs; Coen A Stegeman; gerjan navis; J de Haan; Wim van Der Bij; Wim J de Boer; Dick De Zeeuw; Paul E de Jong
Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(3):256-62.
2000: FH Wapstra; gerjan navis; Paul E de Jong; Dick De Zeeuw
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Journal of the American Society of Nephrology : JASN 2000;11(3):490-6.
1999: P van Paassen; gerjan navis; Paul E de Jong; Dick De Zeeuw
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
European journal of clinical investigation 1999;29(12):1019-26.
1999: Eric De Boer; gerjan navis; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.
Journal of the American Society of Nephrology : JASN 1999;10(11):2359-66.
1999: Wybe D Kloppenburg; Coen A Stegeman; Paul E de Jong; Roel M Huisman
Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(9):2165-72.
1999: Froukje L Ubels; G G van Essen; Paul E de Jong; Coen A Stegeman
Exercise induced macroscopic haematuria: run for a diagnosis?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):2030-1.
1999: J Broekroelofs; Coen A Stegeman; gerjan navis; Paul E de Jong
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):1841-3.
1999: P A de Vries; gerjan navis; Paul E de Jong; Dick De Zeeuw; C Alex Kluppel
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1999;34(2):191-8.
1999: Paul E de Jong; gerjan navis; Dick De Zeeuw
Renoprotective therapy: titration against urinary protein excretion.
Lancet 1999;354(9176):352-3.
1999: E de Boer; gerjan navis; FH Wapstra; Paul E de Jong; Dick De Zeeuw
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.
Kidney international. Supplement 1999;71():S42-6.
1999: Wybe D Kloppenburg; Paul E de Jong; Roel M Huisman
Low calorie intake in dialysis patients: an alternative explanation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(6):1202-4.
1999: Tom J M Tobé; Casper F M Franssen; Jan G Zijlstra; Paul E de Jong; Coen A Stegeman
Hemolytic uremic syndrome due to Capnocytophaga canimorsus bacteremia after a dog bite.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(6):e5.
1999: Wybe D Kloppenburg; Coen A Stegeman; M Hooyschuur; J van der Ven; Paul E de Jong; Roel M Huisman
Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient.
Kidney international 1999;55(5):1961-9.
1999: FH Wapstra; H van Goor; Paul E de Jong; gerjan navis; Dick De Zeeuw
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
Journal of pharmacological and toxicological methods 1999;41(2-3):69-73.
1999: H Buter; gerjan navis; A J Woittiez; Dick De Zeeuw; Paul E de Jong
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function.
European journal of clinical pharmacology 1999;54(12):953-8.
1999: M H Hemmelder; Dick De Zeeuw; Paul E de Jong
Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(1):98-104.
1998: J Broekroelofs; Coen A Stegeman; gerjan navis; Adam M Tegzess; Dick De Zeeuw; Paul E de Jong
Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
Journal of the American Society of Nephrology : JASN 1998;9(11):2075-81.
1998: Marijke Haas Jimoh Akanbi; F Moolenaar; D K Meijer; Paul E de Jong; Dick De Zeeuw
Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
Clinical science (London, England : 1979) 1998;95(5):603-9.
1998: Casper F M Franssen; Coen A Stegeman; WW Oost-Kort; Cees G M Kallenberg; Pieter C Limburg; Anton T M G Tiebosch; Paul E de Jong; J W Cohen Tervaert
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.
Journal of the American Society of Nephrology : JASN 1998;9(10):1915-23.
1998: H Buter; MH Hemmelder; gerjan navis; Paul E de Jong; Dick De Zeeuw
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(7):1682-5.
1998: J Broekroelofs; gerjan navis; Coen A Stegeman; W van der Bij; Paul E de Jong
Lung transplantation.
Lancet 1998;351(9108):1064.
1998: J Koiter; gerjan navis; Paul E de Jong; W H van Gilst; Dick De Zeeuw
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activity.
Journal of pharmacological and toxicological methods 1998;39(1):45-9.
1998: RS de Jong; Elisabeth G E de Vries; S Meijer; Paul E de Jong; Nanno H Mulder
Renal toxicity of the anticancer drug fostriecin.
Cancer chemotherapy and pharmacology 1998;42(2):160-4.
1997: Marijke Haas Jimoh Akanbi; AC Kluppel; E S Wartna; Frits Moolenaar; Dirk K F Meijer; Paul E de Jong; Dick De Zeeuw
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Kidney international 1997;52(6):1693-9.
1997: H Buter; gerjan navis; Dick De Zeeuw; Paul E de Jong
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.
Kidney international. Supplement 1997;63():S185-7.
1997: G G van Essen; Alfred J Apperloo; Pieter L Rensma; Coen A Stegeman; W J Sluiter; Dick De Zeeuw; Paul E de Jong
Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
Kidney international. Supplement 1997;63():S58-62.
1997: Frank G H van Der Kleij; A Schmidt; gerjan navis; M Haas; N Yilmaz; Paul E de Jong; G Mayer; Dick De Zeeuw
Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
Kidney international. Supplement 1997;63():S23-6.
1997: Marijke Haas Jimoh Akanbi; AC Kluppel; Frits Moolenaar; Dirk K F Meijer; Paul E de Jong; Dick De Zeeuw
Urine collection in the freely moving rat: reliability for measurement of short-term renal effects.
Journal of pharmacological and toxicological methods 1997;38(1):47-51.
1997: Wybe D Kloppenburg; BG Wolthers; Frans Stellaard; Henk Elzinga; T Tepper; Paul E de Jong; Roel M Huisman
Determination of urea kinetics by isotope dilution with [13C]urea and gas chromatography-isotope ratio mass spectrometry (GC-IRMS) analysis.
Clinical science (London, England : 1979) 1997;93(1):73-80.
1997: gerjan navis; Dick De Zeeuw; Paul E de Jong
ACE-inhibitors: panacea for progressive renal disease.
Lancet 1997;349(9069):1852-3.
1997: Ron T Gansevoort; gerjan navis; F H Wapstra; Paul E de Jong; Dick De Zeeuw
Proteinuria and progression of renal disease: therapeutic implications.
Current opinion in nephrology and hypertension 1997;6(2):133-40.
1997: Alfred J Apperloo; Dick De Zeeuw; Paul E de Jong
A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function.
Kidney international 1997;51(3):793-7.
1997: gerjan navis; Paul E de Jong; Dick De Zeeuw
Optimizing the renal response to ace inhibition: a strategy toward more effective long-term renoprotection.
Advances in nephrology from the Necker Hospital 1997;27():57-66.
1997: MH Hemmelder; Dick De Zeeuw; Paul E de Jong
Measurement of glomerular charge selectivity in non-diabetic renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():57-62.
1997: H Buter; MH Hemmelder; P van Paassen; gerjan navis; Dick De Zeeuw; Paul E de Jong
Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():53-6.
1997: Frank G H van Der Kleij; gerjan navis; Ron T Gansevoort; J E Heeg; H Scheffer; Dick De Zeeuw; Paul E de Jong
ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():42-6.
1997: gerjan navis; H Buter; Paul E de Jong; R P F Dullaart; Dick De Zeeuw
Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease.
Contributions to nephrology 1997;120():88-96.
1996: W M Janssen; Paul E de Jong; Dick De Zeeuw
Hypertension and renal disease: role of microalbuminuria.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1996;14(5):S173-7.
1996: C A Visscher; Dick De Zeeuw; gerjan navis; A K Van Zanten; Paul E de Jong; Roel M Huisman
Renal 131I-hippurate clearance overestimates true renal blood flow in the instrumented conscious dog.
The American journal of physiology 1996;271(2 Pt 2):F269-74.
1996: Ron T Gansevoort; N D Vaziri; Paul E de Jong
Treatment of anemia of nephrotic syndrome with recombinant erythropoietin.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(2):274-7.
1996: C A Stegeman; J W Tervaert; Paul E de Jong; C G Kallenberg
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
The New England journal of medicine 1996;335(1):16-20.
1996: R P F Dullaart; Ron T Gansevoort; W J Sluiter; Dick De Zeeuw; Paul E de Jong
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment.
Metabolism: clinical and experimental 1996;45(6):723-30.
1996: F H Wapstra; H Van Goor; gerjan navis; Paul E de Jong; Dick De Zeeuw
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
Clinical science (London, England : 1979) 1996;90(5):393-401.
1996: A J Apperloo; Dick De Zeeuw; A J M Donker; Paul E de Jong
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
Journal of the American Society of Nephrology : JASN 1996;7(4):567-72.
1996: C A Visscher; Dick De Zeeuw; Paul E de Jong; D A Piers; H Beekhuis; G M Groothuis; Roel M Huisman
Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(3):482-8.
1996: P van Paassen; Dick De Zeeuw; gerjan navis; Paul E de Jong
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
Hypertension 1996;27(2):202-8.
1996: G G van Essen; P L Rensma; Dick De Zeeuw; W J Sluiter; H Scheffer; A J Apperloo; Paul E de Jong
Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.
Lancet 1996;347(8994):94-5.
1996: F H Wapstra; gerjan navis; Paul E de Jong; Dick De Zeeuw
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.
Experimental nephrology 1996;4 Suppl 1():47-52.
1996: M H Hemmelder; Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition.
Kidney international 1996;49(1):174-80.
1995: Ron T Gansevoort; W J Sluiter; M H Hemmelder; Dick De Zeeuw; Paul E de Jong
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(11):1963-74.
1995: C A Visscher; Dick De Zeeuw; Paul E de Jong; W J Sluiter; Roel M Huisman
Drug-induced changes in renal hippurate clearance as a measure of renal blood flow.
Kidney international 1995;48(5):1617-23.
1995: W M Janssen; H Beekhuis; R de Bruin; Paul E de Jong; Dick De Zeeuw
Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling.
The American journal of physiology 1995;269(4 Pt 2):F571-80.
1995: Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Losartan in patients with renal insufficiency.
The Canadian journal of cardiology 1995;11 Suppl F():41F-44F.
1995: Dick De Zeeuw; Ron T Gansevoort; R P F Dullaart; Paul E de Jong
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(1):S53-8.
1995: M H Hemmelder; Dick De Zeeuw; Vaclav Fidler; Paul E de Jong
Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease?
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):187-92.
1995: P van Paassen; Dick De Zeeuw; Paul E de Jong
Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
Journal of cardiovascular pharmacology 1995;26(1):39-45.
1995: Coen A Stegeman; R M Huisman; B de Rouw; A Joostema; Paul E de Jong
Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: urea output measurements compared with dietary protein intake and with calculation of urea generation rate.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(6):887-95.
1995: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(4):497-504.
1994: A J Apperloo; Dick De Zeeuw; Paul E de Jong
Discordant effects of enalapril and lisinopril on systemic and renal hemodynamics.
Clinical pharmacology and therapeutics 1994;56(6 Pt 1):647-58.
1994: Coen A Stegeman; J W Cohen Tervaert; Minke G Huitema; Paul E de Jong; Cees G M Kallenberg
Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup.
Arthritis and rheumatism 1994;37(8):1228-35.
1994: Ron T Gansevoort; Dick De Zeeuw; S Shahinfar; A Redfield; Paul E de Jong
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S37-42.
1994: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Journal of hypertension 1994;12(4):439-47.
1994: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Kidney international 1994;45(3):861-7.
1994: A J Apperloo; Dick De Zeeuw; Paul E de Jong
Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.
Kidney international. Supplement 1994;45():S174-8.
1994: Ron T Gansevoort; J E Heeg; F D Dikkeschei; Dick De Zeeuw; Paul E de Jong; R P F Dullaart
Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(3):244-50.
1994: gerjan navis; R P F Dullaart; Edo Vellenga; J D Elema; Paul E de Jong
Renal disease in POEMS syndrome: report on a case and review of the literature.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(10):1477-81.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition.
Kidney international 1993;44(3):579-84.
1993: R P F Dullaart; Ron T Gansevoort; B D Dikkeschei; Dick De Zeeuw; Paul E de Jong; Arie Van Tol
Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
Kidney international 1993;44(1):91-7.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(1):202-6.
1992: P L Rensma; A J Apperloo; Paul E de Jong
Antibiotic dose adjustment in renal insufficiency.
Lancet 1992;340(8833):1479-80; author reply 1480-1.
1992: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Hypertension 1992;20(1):80-4.
1992: Ron T Gansevoort; F H Wapstra; J J Weening; Paul E de Jong; Dick De Zeeuw
Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.
Nephron 1992;60(2):246-7.
1992: Paul E de Jong; J E Heeg; A J Apperloo; Dick De Zeeuw
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.
Journal of cardiovascular pharmacology 1992;19 Suppl 6():S28-32.
1992: Ron T Gansevoort; J E Heeg; R Vriesendorp; Dick De Zeeuw; Paul E de Jong
Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7 Suppl 1():91-6.
1991: Dick De Zeeuw; G J Jonker; T K Hovinga; H Beekhuis; D A Piers; Roel M Huisman; Paul E de Jong
The mechanism and diagnostic value of angiotensin I converting enzyme inhibition renography.
American journal of hypertension 1991;4(12 Pt 2):741S-744S.
1991: A J Apperloo; Dick De Zeeuw; H E Sluiter; Paul E de Jong
Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.
BMJ (Clinical research ed.) 1991;303(6806):821-4.
1991: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Kidney international 1991;40(4):734-41.
1991: J E Heeg; Paul E de Jong; Dick De Zeeuw
Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
Clinical science (London, England : 1979) 1991;81(3):367-72.
1991: Paul E de Jong; J E Heeg; A J Apperloo; Dick De Zeeuw
Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(5 Suppl 1):85-8.
1991: E J ter Borg; Paul E de Jong; Sybren Meijer; Cees G M Kallenberg
Tubular dysfunction in proliferative lupus nephritis.
American journal of nephrology 1991;11(1):16-22.
1990: J E Heeg; Paul E de Jong; R Vriesendorp; Dick De Zeeuw
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
American journal of nephrology 1990;10 Suppl 1():94-7.
1990: Paul E de Jong; A J Apperloo; J E Heeg; Dick De Zeeuw
Lisinopril in hypertensive patients with renal function impairment.
Nephron 1990;55 Suppl 1():43-8.
1990: T K Kremer Hovinga; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Relief of renal artery stenosis: a tool to improve or preserve renal function in renovascular disease?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(7):481-8.
1990: A S Dofferhoff; H E Sluiter; W Geerlings; Paul E de Jong
Complications of liver cysts in patients with adult polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(10):882-5.
1990: Dick De Zeeuw; J E Heeg; T Stelwagen; R J de Jong; Paul E de Jong
Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.
Contributions to nephrology 1990;83():160-5.
1989: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
Kidney international 1989;36(2):272-9.
1989: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism.
Clinical science (London, England : 1979) 1989;77(1):55-60.
1989: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans.
Hypertension 1989;13(6 Pt 1):640-6.
1989: T K Kremer Hovinga; Paul E de Jong; D A Piers; H Beekhuis; G K van der Hem; Dick De Zeeuw
Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(5):605-14.
1989: E J ter Borg; Paul E de Jong; Sybren Meijer; C G Kallenberg
Renal effects of indomethacin in patients with systemic lupus erythematosus.
Nephron 1989;53(3):238-43.
1989: P H B Willemse; Paul E de Jong; J D Elema; Nanno H Mulder
Severe renal failure following high-dose ifosfamide and mesna.
Cancer chemotherapy and pharmacology 1989;23(5):329-30.
1988: W M Janssen; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Involvement of atrial natriuretic peptide in long-term regulation of sodium-homeostasis in man.
Clinical nephrology 1988;30(3):172.
1988: Dick De Zeeuw; R Tomasini; Marijke Haas Jimoh Akanbi; Paul E de Jong; J J Weening; G K van der Hem
Effect of mild charge modification of albumin on renal excretion in the rat.
Contributions to nephrology 1988;68():121-7.
1988: Paul E de Jong; J van der Meer; G K van der Hem; Dick De Zeeuw
Is the antiproteinuric effect of dipyridamole hemodynamically mediated?
Nephron 1988;50(4):292-4.
1987: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Reduction of proteinuria by angiotensin converting enzyme inhibition.
Kidney international 1987;32(1):78-83.
1986: T K Hovinga; Paul E de Jong; Dick De Zeeuw; K H Schuur; G K Van der Hem
Short-term effects of percutaneous transluminal renal angioplasty on renal function in unilateral renal artery stenosis.
The Netherlands journal of medicine 1986;29(11):347-51.
1986: T K Kremer Hovinga; Paul E de Jong; Dick De Zeeuw; A J Donker; K H Schuur; G K van der Hem
Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty.
Nephron 1986;44 Suppl 1():64-7.
1983: K J Kuiper; Paul E de Jong; Dick De Zeeuw; K H Schuur; G K van der Hem
Restenosis of the renal artery after percutaneous transluminal renal angioplasty: an inevitable outcome?
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;20():538-45.
1983: Paul E de Jong; Dick De Zeeuw; A J Smit; S J Hoorntje; K H Schuur; A J Donker; G K Van der Hem
The effect of transluminal dilation of stenosed renal arteries on kidney function.
The Netherlands journal of medicine 1983;26(9):266-70.